Clinical Trials About "Mobius Bionics" RSS

12:23 EDT 22nd July 2019 | BioPortfolio

We list hundreds of Clinical Trials about "Mobius Bionics" on BioPortfolio. We draw our references from global clinical trials data listed on and refresh our database daily.

More Information about "Mobius Bionics" on BioPortfolio

We have published hundreds of Mobius Bionics news stories on BioPortfolio along with dozens of Mobius Bionics Clinical Trials and PubMed Articles about Mobius Bionics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Mobius Bionics Companies in our database. You can also find out about relevant Mobius Bionics Drugs and Medications on this site too.

Showing "Mobius Bionics" Clinical Trials, all 11

Friday 5th July 2019

Pilot Study of Powered Exoskeleton Use for Gait Rehabilitation in Individuals With Multiple Sclerosis

The investigator plans to test the use of the Ekso Bionics® Gait Training (Ekso GT™) exoskeleton for gait training in MS patients. The device will solely be used in the clinic under direct supervision from a physical therapist. This is a small PI-initiated uncontrolled pilot study to gather safety and feasibility data on the exoskeleton in individuals with MS and walking impairment.

Wednesday 6th March 2019

Electrode Placement and Audiologic Outcomes With the Advanced Bionics HiFocus L23 Electrode

The goal of this study is to measure patient performance after cochlear implantation with the FDA approved Advanced Bionics HiFocus L23 device. The specific aims of the project are as follows: 1. To measure implant audiologic performance as defined by speech performance in standard cochlear implant speech test batteries. 2. To determine scalar location after insertion through either intraoperative or postoperative imaging and correlate this with audiologi...

Thursday 24th January 2019

Exploring the Use of ECochG Testing During Electrode Insertion in Cochlear Implant Surgery

Investigation of a new ECoChG system (Electrocochleography) during the surgical insertion of cochlear implants, for patients with Advanced Bionics devices. The sound recordings created may be useful in aiding the surgeon to better implant the patient by letting him or her know if they are damaging the ear during implantation in real time Patients will be followed up for 1 year post surgery within our trial, and have a further 3 ECochGs performed in the clinic setting, (...

Wednesday 17th October 2018

BIONICS 38 mm Trial EluNIR Ridaforolimus Eluting Coronary Stent System (EluNIR) In Coronary Stenosis Trial

This is a prospective, multi-center, single-arm, open-label clinical trial. Clinical follow-up will be performed at 30 days. Follow-up by phone will be performed at 6 months, and 1 year after the procedure. Study Objective is to further assess the safety and efficacy of long (38 mm) Ridaforolimus Eluting Stent - EluNIR.

Wednesday 13th June 2018

The Efficacy and Safety of a New Power Exoskeleton Robot for Improving Walking Ability in Spinal Cord Injury Patients

In Taiwan, there are more than 23,000 individuals with spinal cord injuries (SCI, mean age: 27 years), with an increment of new 1,200 SCI individuals each year. Recovery of ambulatory function is among the most important therapeutic goals because 92% of the individuals with SCI have to use the wheelchair for the rest of their lives. The lower limb powered exoskeleton robot, FREE Walk, used for training in this research was developed by FREE Bionics Inc. The main purpose of thi...

Monday 18th July 2016

BIONICS Israel Trial

This study aims to assess the device success and the safety of Medinol's Drug Eluting Stent - BioNIR - with a modified delivery system. The BioNIR Ridaforolimus Eluting Coronary Stent System is a single use device/drug combination product comprising: - A mounted Cobalt Chromium (CoCr) alloy based stent - A Rapid Exchange (RX) delivery system - A polymer matrix coating - Poly n-butyl methacrylate (PBMA) and CarboSil® - Ridaforolimus drug - CAS Registry Num...

Monday 5th October 2015

Investigational Study of the Ekso Bionics Powered Exoskeleton for High-Dosage Use by Individuals With SCI in a Non-Clinical Environment

The purpose of the study is to study the safety and health effects of using the Ekso Bionics powered exoskeleton device in a home setting over a 12-36 month period.

Wednesday 27th August 2014

Positive Exposure: A Photography and Video Intervention for Individuals With Craniofacial Differences

This study will describe the use of an intervention, developed by an organization called Positive Exposure, to improve self-perceptions among adolescents and young adults who may encounter the stigma, or negative effect, of differences in their head and face. Photo-shoots and video interviews will be used. The combined use of those techniques is a new way to address aspects such as self-esteem, body image, and feelings of social awkwardness and anxiety-that is, a way that has n...

Impairments of Oral Language in Mobius Syndrome

The Möbius syndrome constitutes a congenital disorder classically caused by genetic and environmental factors. The clinical manifestations include lesion of the facial and abducens nerves associated with limb malformations specially club foot. The speech-language manifestations include compromise of oral and deglutition, speech and language functions, secondary to cranial nerves lesions and mental retardation. The language compromise in this disorder is still not well known....

Thursday 24th July 2014

Spinal Cord Stimulation for Low Back Pain

The purpose of this study is to assess the acute and chronic effectiveness of the Advanced Bionics Precision(TM) Spinal Cord Stimulation System in subjects with failed back surgery syndrome and associated low back axial pain. Subjects will undergo a temporary or permanent trial to assess their candidacy for placement of an implantable pulse generator. Those who demonstrate a significant clinical reduction in pain will be enrolled in the chronic study. Subjects will be followed...

Mobius® Post-cesarean Pain Randomized Control Trial

The purpose of this study is to investigate whether the use of the Mobius® retractor decreased post-operative pain after cesarean section verses conventional retractor use. Based on clinical experience and a pilot study, we suspect that the retractor will decrease overall pain as well as lateral pain.

More From BioPortfolio on "Mobius Bionics"

Quick Search